BAP1 and Miyoshi myopathy: Compared to the reported somatic frameshift mutations of BAP1 in the Catalogue of Somatic Mutations in Cancer (COSMIC) database, the neo-antigen of the Bap1 protein is an ideal biomarker for molecular diagnosis and precisely subtyping of MM.